Which cancer-related conditions or treatments make naloxegol contraindicated because of gastrointestinal perforation risk?

Naloxegol is contraindicated in patients with cancer pain and underlying cancer at heightened gastrointestinal perforation risk, such as gastrointestinal tract or peritoneal malignancies, recurrent or advanced ovarian cancer, or vascular endothelial growth factor (VEGF) inhibitor treatment.